•  
  •  
  •  
  •  

2025-09-28 06:29:11

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Anand Rayons Ltd receives approval for STAPII trademark
  • IRFC extends funding support to PVUNL for INR 3,388.51 crore
  • Zaggle Prepaid Ocean Services Ltd enters into agreement with IDFC First Bank Ltd
  • PNG Jewellers expands National Footprint, Celebrates Lucknow's Cultural Legacy with Maiden Store Launch
  • Interarch strengthens presence in Multi-Storey Steel Buildings with new plant in Attivaram, Andhra Pradesh

Keywords Selected:  Injection

Stock Report

  • Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer
  • Glenmark Pharmaceuticals Inc., USA to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) Single-Dose Vials
  • Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial
  • Gland Pharma receives approval from USFDA for Cangrelor for Injection 50 mg/vial
  • Lupin Launches Glucagon for Injection USP, 1mg/Vial in the United States
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials
  • Gland Pharma Receives Approval for Angiotensin II Acetate Injection
  • Caplin Steriles Ltd receives USFDA final approval for ANDA Haloperidol Decanoate Injection
  • Gland Pharma receives approval for Acetaminophen Injection
  • Amneal Pharmaceuticals launches 2nd NDA Bortezomib for injection3.5mg/1.4ml in US
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Pantoprazole Sodium for Injection, 40 mg/vial - Single-Dose Vial
  • Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)
  • Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial
  • Caplin Steriles gets USFDA approval for Levetiracetam in Sodium Chloride Injection, Infusion Bags
  • Pricol Ltd announces Strategic Acquisition of Sundaram Auto Components Ltd's Injection Moulding Business
  • Wockhardt files fast-acting Insulin Aspart injection with DCGI
  • Windsor Machines Ltd launches India's largest two-platen injection moulding machine
  • Eugia Steriles Pvt Ltd receives 1st production approval from USFDA from new injectable facility
  • Shilpa Medicare Ltd announces USFDA Approval for Bortezomib Injection NDA 212782
  • Alembic Pharmaceuticals announces USFDA Final Approval for Nelarabine Injection, 250 mg/50 mL
  • Caplin Steriles Ltd gets USFDA approval for Ephedrine Sulfate injection USP
  • Alembic Pharmaceuticals announces USFDA Tentative Approval for Selexipag for Injection, 1,800 mcg/vial
  • Alembic Pharmaceuticals announces USFDA Final Approval for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe

Latest Post

  • Anand Rayons Ltd receives approval for STAPII trademark
  • IRFC extends funding support to PVUNL for INR 3,388.51 crore
  • Zaggle Prepaid Ocean Services Ltd enters into agreement with IDFC First Bank Ltd
  • PNG Jewellers expands National Footprint, Celebrates Lucknow's Cultural Legacy with Maiden Store Launch
  • Interarch strengthens presence in Multi-Storey Steel Buildings with new plant in Attivaram, Andhra Pradesh


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024